Barclays PLC boosted its stake in shares of DocuSign, Inc. (NASDAQ:DOCU - Free Report) by 113.3% during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 623,002 shares of the company's stock after purchasing an additional 330,861 shares during the period. Barclays PLC owned approximately 0.31% of DocuSign worth $56,031,000 at the end of the most recent reporting period.
Other hedge funds have also recently made changes to their positions in the company. FMR LLC raised its position in DocuSign by 178.2% during the 4th quarter. FMR LLC now owns 6,101,024 shares of the company's stock worth $548,726,000 after buying an additional 3,908,139 shares during the last quarter. American Century Companies Inc. increased its stake in shares of DocuSign by 18.5% in the 4th quarter. American Century Companies Inc. now owns 5,315,459 shares of the company's stock valued at $478,072,000 after purchasing an additional 831,611 shares in the last quarter. Renaissance Technologies LLC raised its stake in shares of DocuSign by 4.9% during the 4th quarter. Renaissance Technologies LLC now owns 4,363,292 shares of the company's stock worth $392,434,000 after buying an additional 205,304 shares during the period. Geode Capital Management LLC lifted its holdings in DocuSign by 7.2% during the fourth quarter. Geode Capital Management LLC now owns 3,732,363 shares of the company's stock valued at $335,147,000 after purchasing an additional 249,179 shares in the last quarter. Finally, Invesco Ltd. boosted its holdings in DocuSign by 283.9% in the 4th quarter. Invesco Ltd. now owns 3,447,275 shares of the company's stock worth $310,048,000 after buying an additional 2,549,310 shares during the last quarter. 77.64% of the stock is owned by institutional investors and hedge funds.
Wall Street Analysts Forecast Growth
A number of equities research analysts have recently commented on DOCU shares. Needham & Company LLC reiterated a "hold" rating on shares of DocuSign in a research report on Thursday, April 17th. HSBC upgraded shares of DocuSign from a "reduce" rating to a "hold" rating and set a $70.00 price objective on the stock in a report on Friday, April 11th. Bank of America decreased their price target on shares of DocuSign from $112.00 to $98.00 and set a "neutral" rating for the company in a research report on Friday, March 14th. William Blair restated an "outperform" rating on shares of DocuSign in a research note on Monday. Finally, JPMorgan Chase & Co. upgraded DocuSign from an "underweight" rating to a "neutral" rating and upped their price target for the stock from $70.00 to $75.00 in a research note on Monday, March 10th. One investment analyst has rated the stock with a sell rating, eleven have assigned a hold rating and four have issued a buy rating to the stock. According to data from MarketBeat, the company has a consensus rating of "Hold" and a consensus price target of $92.46.
View Our Latest Analysis on DOCU
Insider Buying and Selling at DocuSign
In other DocuSign news, CFO Blake Jeffrey Grayson sold 8,000 shares of the company's stock in a transaction that occurred on Friday, February 14th. The stock was sold at an average price of $86.90, for a total value of $695,200.00. Following the completion of the sale, the chief financial officer now directly owns 77,851 shares in the company, valued at $6,765,251.90. This represents a 9.32 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, Director Teresa Briggs sold 534 shares of the firm's stock in a transaction dated Monday, March 17th. The shares were sold at an average price of $87.41, for a total value of $46,676.94. Following the transaction, the director now directly owns 8,270 shares of the company's stock, valued at $722,880.70. This represents a 6.07 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold 55,851 shares of company stock worth $4,607,439 over the last quarter. 1.66% of the stock is owned by corporate insiders.
DocuSign Stock Up 2.2 %
Shares of DocuSign stock traded up $1.56 during trading hours on Tuesday, hitting $73.45. The company's stock had a trading volume of 164,359 shares, compared to its average volume of 2,724,823. DocuSign, Inc. has a 1-year low of $48.70 and a 1-year high of $107.86. The business has a fifty day moving average of $81.02 and a 200 day moving average of $83.44. The company has a market capitalization of $14.87 billion, a PE ratio of 15.15, a P/E/G ratio of 6.94 and a beta of 1.20.
DocuSign (NASDAQ:DOCU - Get Free Report) last announced its earnings results on Thursday, March 13th. The company reported $0.86 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.84 by $0.02. DocuSign had a return on equity of 14.90% and a net margin of 34.73%. The business had revenue of $776.25 million for the quarter, compared to analyst estimates of $760.94 million. During the same period in the previous year, the company earned $0.76 earnings per share. The company's revenue for the quarter was up 9.0% compared to the same quarter last year. On average, sell-side analysts anticipate that DocuSign, Inc. will post 1.17 earnings per share for the current fiscal year.
DocuSign Profile
(
Free Report)
DocuSign, Inc provides electronic signature solution in the United States and internationally. The company provides e-signature solution that enables sending and signing of agreements on various devices; Contract Lifecycle Management (CLM), which automates workflows across the entire agreement process; Document Generation streamlines the process of generating new, custom agreements; and Gen for Salesforce, which allows sales representatives to automatically generate agreements with a few clicks from within Salesforce.
Read More

Before you consider DocuSign, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and DocuSign wasn't on the list.
While DocuSign currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat's analysts have just released their top five short plays for May 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.